Condition: Phenylketonuria (PKU) · Sponsor: University Hospital, Tours
The GENOPHEN study aims to explore the links between the genome, metabolomic profile, and clinical phenotype in adults with early-treated PKU.
This description comes directly from the study's public registry record.
François MAILLOT, Pr · 2.47.47.37.15 · francois.maillot@univ-tours.fr
Always discuss trial participation with your own doctor first.
| University hospital | Angers, France | Not Yet Recruiting |
| University hospital | Bordeaux, France | Not Yet Recruiting |
| University hospital | Brest, France | Not Yet Recruiting |
| University hospital | Dijon, France | Not Yet Recruiting |
| University hospital | Grenoble, France | Not Yet Recruiting |
| University hospital | Lille, France | Not Yet Recruiting |
| Civil Hospitals | Lyon, France | Not Yet Recruiting |
| Conception hospital | Marseille, France | Not Yet Recruiting |
| University hospital | Nancy, France | Not Yet Recruiting |
| University hospital | Nantes, France | Not Yet Recruiting |
| Necker hospital | Paris, France | Not Yet Recruiting |
| University hospital | Rennes, France | Not Yet Recruiting |
+ 3 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07484945